Phosphoinositide 3-Kinase Inhibitor Market, Global Outlook and Forecast 2022-2028

May 2022 | 64 pages | ID: PBDF2ED2C1C7EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Phosphoinositide 3-Kinase Inhibitor in Global, including the following market information:

Global Phosphoinositide 3-Kinase Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Phosphoinositide 3-Kinase Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pan-PI3K Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Phosphoinositide 3-Kinase Inhibitor include Bayer AG, Gilead Sciences Inc., Novartis AG, TG Therapeutics Inc. and Secura Bio, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Phosphoinositide 3-Kinase Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Phosphoinositide 3-Kinase Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Phosphoinositide 3-Kinase Inhibitor Market Segment Percentages, by Type, 2021 (%)

• Pan-PI3K Inhibitors
• Dual PI3K/mTOR inhibitors
• Other

Global Phosphoinositide 3-Kinase Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Phosphoinositide 3-Kinase Inhibitor Market Segment Percentages, by Application, 2021 (%)

• CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
• FL - Follicular Iymphoma
• Other Indications

Global Phosphoinositide 3-Kinase Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Phosphoinositide 3-Kinase Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Phosphoinositide 3-Kinase Inhibitor revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Phosphoinositide 3-Kinase Inhibitor revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer AG
• Gilead Sciences Inc.
• Novartis AG
• TG Therapeutics Inc.
• Secura Bio, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Phosphoinositide 3-Kinase Inhibitor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Phosphoinositide 3-Kinase Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHOSPHOINOSITIDE 3-KINASE INHIBITOR OVERALL MARKET SIZE

2.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size: 2021 VS 2028
2.2 Global Phosphoinositide 3-Kinase Inhibitor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Phosphoinositide 3-Kinase Inhibitor Players in Global Market
3.2 Top Global Phosphoinositide 3-Kinase Inhibitor Companies Ranked by Revenue
3.3 Global Phosphoinositide 3-Kinase Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Phosphoinositide 3-Kinase Inhibitor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Phosphoinositide 3-Kinase Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Phosphoinositide 3-Kinase Inhibitor Players in Global Market
  3.6.1 List of Global Tier 1 Phosphoinositide 3-Kinase Inhibitor Companies
  3.6.2 List of Global Tier 2 and Tier 3 Phosphoinositide 3-Kinase Inhibitor Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Phosphoinositide 3-Kinase Inhibitor Market Size Markets, 2021 & 2028
  4.1.2 Pan-PI3K Inhibitors
  4.1.3 Dual PI3K/mTOR inhibitors
  4.1.4 Other
4.2 By Type - Global Phosphoinositide 3-Kinase Inhibitor Revenue & Forecasts
  4.2.1 By Type - Global Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2022
  4.2.2 By Type - Global Phosphoinositide 3-Kinase Inhibitor Revenue, 2023-2028
  4.2.3 By Type - Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Phosphoinositide 3-Kinase Inhibitor Market Size, 2021 & 2028
  5.1.2 CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
  5.1.3 FL - Follicular Iymphoma
  5.1.4 Other Indications
5.2 By Application - Global Phosphoinositide 3-Kinase Inhibitor Revenue & Forecasts
  5.2.1 By Application - Global Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2022
  5.2.2 By Application - Global Phosphoinositide 3-Kinase Inhibitor Revenue, 2023-2028
  5.2.3 By Application - Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Phosphoinositide 3-Kinase Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Phosphoinositide 3-Kinase Inhibitor Revenue & Forecasts
  6.2.1 By Region - Global Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2022
  6.2.2 By Region - Global Phosphoinositide 3-Kinase Inhibitor Revenue, 2023-2028
  6.2.3 By Region - Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2028
  6.3.2 US Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.3.3 Canada Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.3.4 Mexico Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2028
  6.4.2 Germany Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.4.3 France Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.4.4 U.K. Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.4.5 Italy Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.4.6 Russia Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.4.7 Nordic Countries Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.4.8 Benelux Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2028
  6.5.2 China Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.5.3 Japan Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.5.4 South Korea Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.5.5 Southeast Asia Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.5.6 India Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2028
  6.6.2 Brazil Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.6.3 Argentina Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2028
  6.7.2 Turkey Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.7.3 Israel Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.7.4 Saudi Arabia Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028
  6.7.5 UAE Phosphoinositide 3-Kinase Inhibitor Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Corporate Summary
  7.1.2 Bayer AG Business Overview
  7.1.3 Bayer AG Phosphoinositide 3-Kinase Inhibitor Major Product Offerings
  7.1.4 Bayer AG Phosphoinositide 3-Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.1.5 Bayer AG Key News
7.2 Gilead Sciences Inc.
  7.2.1 Gilead Sciences Inc. Corporate Summary
  7.2.2 Gilead Sciences Inc. Business Overview
  7.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Major Product Offerings
  7.2.4 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.2.5 Gilead Sciences Inc. Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Phosphoinositide 3-Kinase Inhibitor Major Product Offerings
  7.3.4 Novartis AG Phosphoinositide 3-Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 TG Therapeutics Inc.
  7.4.1 TG Therapeutics Inc. Corporate Summary
  7.4.2 TG Therapeutics Inc. Business Overview
  7.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Major Product Offerings
  7.4.4 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.4.5 TG Therapeutics Inc. Key News
7.5 Secura Bio, Inc.
  7.5.1 Secura Bio, Inc. Corporate Summary
  7.5.2 Secura Bio, Inc. Business Overview
  7.5.3 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Major Product Offerings
  7.5.4 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Revenue in Global Market (2017-2022)
  7.5.5 Secura Bio, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Phosphoinositide 3-Kinase Inhibitor Market Opportunities & Trends in Global Market
Table 2. Phosphoinositide 3-Kinase Inhibitor Market Drivers in Global Market
Table 3. Phosphoinositide 3-Kinase Inhibitor Market Restraints in Global Market
Table 4. Key Players of Phosphoinositide 3-Kinase Inhibitor in Global Market
Table 5. Top Phosphoinositide 3-Kinase Inhibitor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Phosphoinositide 3-Kinase Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Phosphoinositide 3-Kinase Inhibitor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Phosphoinositide 3-Kinase Inhibitor Product Type
Table 9. List of Global Tier 1 Phosphoinositide 3-Kinase Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Phosphoinositide 3-Kinase Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Phosphoinositide 3-Kinase Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Phosphoinositide 3-Kinase Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Phosphoinositide 3-Kinase Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Phosphoinositide 3-Kinase Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Phosphoinositide 3-Kinase Inhibitor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Phosphoinositide 3-Kinase Inhibitor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Phosphoinositide 3-Kinase Inhibitor Product Offerings
Table 32. Bayer AG Phosphoinositide 3-Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Sciences Inc. Corporate Summary
Table 34. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Product Offerings
Table 35. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Phosphoinositide 3-Kinase Inhibitor Product Offerings
Table 38. Novartis AG Phosphoinositide 3-Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 39. TG Therapeutics Inc. Corporate Summary
Table 40. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Product Offerings
Table 41. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 42. Secura Bio, Inc. Corporate Summary
Table 43. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Product Offerings
Table 44. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Phosphoinositide 3-Kinase Inhibitor Segment by Type in 2021
Figure 2. Phosphoinositide 3-Kinase Inhibitor Segment by Application in 2021
Figure 3. Global Phosphoinositide 3-Kinase Inhibitor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Phosphoinositide 3-Kinase Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Phosphoinositide 3-Kinase Inhibitor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Phosphoinositide 3-Kinase Inhibitor Revenue in 2021
Figure 8. By Type - Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 12. US Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 16. Germany Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 17. France Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 24. China Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 28. India Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 30. Brazil Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Revenue Market Share, 2017-2028
Figure 33. Turkey Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Phosphoinositide 3-Kinase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Phosphoinositide 3-Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Phosphoinositide 3-Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)